Clinical Trial Update: Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing simultaneous modulated accelerated boost to standard-dose radiotherapy in esophageal cancer is ongoing with status UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Chuangzhen Chen | Conditions: Esophageal Cancer | Phase 3 | Status: UNKNOWN